In a few years’ time, yttrium oxide gel microspheres, produced at the National Centre for Nuclear Research (NCBJ) in Świerk, could be new agents to fight liver cancer. The results of recent studies on the effects of the new microspheres on biological material are promising.
Malignant liver tumours are dangerous diseases with a high mortality rate. One promising method of treating them is radioembolisation. During this procedure, millions of radioactive microspheres are inserted into the tumour tissue.
There is growing evidence that, in future, these microspheres can be produced quickly and cheaply to suit the therapeutic needs and anatomy of specific patients. Such conclusions can be drawn from experiments on new microspheres with the yttrium isotope 90Y, produced and studied by a team of employees from the Warsaw scientific and medical institutes with the participation of the National Centre for Nuclear Research (NCBJ) in Świerk.